BioSense is a ground-breaking startup revolutionizing health and wellness monitoring systems. Established in 2015, the company's flagship product is an ECG sensor with the ability to detect heart signals through multiple layers of fabric without direct skin contact. The innovative non-contact ECG solution captures the body’s electrical heartbeat signal effortlessly, introducing a touchless approach to heart health.
With a focus on analytics, health care, and health and wellness, BioSense has garnered attention from investors, receiving a grant investment in February 2020 from the Consortium For Technology & Innovation in Pediatrics.
